Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chew

Showing results (741-750 of 758) with videos related to

Pageof 76
Sort By:
The Lancet Regional Health. Western Pacific|September 11, 2023
Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohortNicholas W S Chew, Bryan Chong, Si Min Kuo, et al.
Cell Reports|July 24, 2025
Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large moleculesRobert C Wells, Padma Akkapeddi, Darren Chan, et al.
Annals of Intensive Care|January 29, 2021
Current use of inotropes in circulatory shockThomas W L Scheeren, Jan Bakker, Thomas Kaufmann, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Journal of the American College of Cardiology|September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art ReviewGemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Science Translational Medicine|August 14, 2024
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrierScarlett J Barker, Mai B Thayer, Chaeyoung Kim, et al.
Burns : Journal of the International Society for Burn Injuries|October 15, 2023
Surviving Sepsis After Burn CampaignDavid G Greenhalgh, David M Hill, David M Burmeister, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Pageof 76

Showing results (741-750 of 758) with videos related to

Sort By:
Pageof 76
The Lancet Regional Health. Western Pacific|September 11, 2023
Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohortNicholas W S Chew, Bryan Chong, Si Min Kuo, et al.
Cell Reports|July 24, 2025
Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large moleculesRobert C Wells, Padma Akkapeddi, Darren Chan, et al.
Annals of Intensive Care|January 29, 2021
Current use of inotropes in circulatory shockThomas W L Scheeren, Jan Bakker, Thomas Kaufmann, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Journal of the American College of Cardiology|September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art ReviewGemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Science Translational Medicine|August 14, 2024
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrierScarlett J Barker, Mai B Thayer, Chaeyoung Kim, et al.
Burns : Journal of the International Society for Burn Injuries|October 15, 2023
Surviving Sepsis After Burn CampaignDavid G Greenhalgh, David M Hill, David M Burmeister, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Pageof 76